Immediate-release onapristone
Term · Oncology and biomedicine · MLC-T-ONC-014381
An immediate-release (IR) formulation of onapristone, an orally bioavailable progesterone receptor (PR) antagonist, with antineoplastic activity. Onapristone binds to the PR and inhibits both PR activation and the associated expression of PR-responsive genes. This may inhibit PR-mediated proliferative effects in cancer cells overexpressing PR. PR is expressed in certain cancer cell types and plays a key role in proliferation and survival.
| Identifier | MLC-T-ONC-014381 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | onapristone, immediate-release formulation; IR onapristone |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014381",
"term": "Immediate-release onapristone",
"field": "Oncology and biomedicine",
"definition": "An immediate-release (IR) formulation of onapristone, an orally bioavailable progesterone receptor (PR) antagonist, with antineoplastic activity. Onapristone binds to the PR and inhibits both PR activation and the associated expression of PR-responsive genes. This may inhibit PR-mediated proliferative effects in cancer cells overexpressing PR. PR is expressed in certain cancer cell types and plays a key role in proliferation and survival.",
"synonyms": [
"onapristone, immediate-release formulation",
"IR onapristone"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/immediate-release-onapristone/"
}
Record 9,064 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.